Supernus Pharmaceuticals (SUPN) Operating Expenses (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Operating Expenses of $277.0 million for Q2 2026, up 80.69% year-over-year from $153.3 million in Q2 2025, and up 28.54% on a QoQ basis from $215.5 million in Q4 2025.
Supernus Pharmaceuticals (SUPN) Operating Expenses (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Operating Expenses for 16 years, with the latest figure at $277.0 million in Q2 2026.
- Operating Expenses for Q2 2026 came in at $277.0 million, up 80.69% year-over-year; the trailing twelve-month figure through Jun 2026 was $744.9 million (up 23.94% YoY), and the FY2025 annual result was $781.2 million, up 34.66% from the prior year.
- Operating Expenses advanced to $277.0 million in Q2 2026, from $215.5 million in the prior quarter.
- Over five years, Operating Expenses peaked at $277.0 million in Q2 2026 and troughed at $133.0 million in Q4 2022.
- A 5-year average of $169.0 million and a median of $153.2 million in 2023 frame the typical range for Operating Expenses.
- The widest annual swing landed in 2023, when Operating Expenses dropped 18.52%; it then soared 87.13% in 2025.
- A 5-year view of Operating Expenses shows it stood at $133.0 million in 2022, then rose by 24.3% to $165.3 million in 2023, then dropped by 7.6% to $152.8 million in 2024, then soared by 41.08% to $215.5 million in 2025, then rose by 28.54% to $277.0 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $277.0 million in Q2 2026, $215.5 million in Q4 2025, and $252.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn | 277.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 277.02 Mn |
| Dec 31, 2025 | 215.51 Mn |
| Sep 30, 2025 | 252.33 Mn |
| Jun 30, 2025 | 153.31 Mn |
| Mar 31, 2025 | 160.08 Mn |
| Dec 31, 2024 | 152.75 Mn |
| Sep 30, 2024 | 134.84 Mn |
| Jun 30, 2024 | 145.76 Mn |
| Mar 31, 2024 | 146.80 Mn |
| Dec 31, 2023 | 165.31 Mn |
| Sep 30, 2023 | 145.74 Mn |
| Jun 30, 2023 | 153.15 Mn |
| Mar 31, 2023 | 148.59 Mn |
| Dec 31, 2022 | 132.99 Mn |
| Sep 30, 2022 | 178.88 Mn |
| Jun 30, 2022 | 158.71 Mn |
| Mar 31, 2022 | 150.54 Mn |
| Dec 31, 2021 | 152.95 Mn |
| Sep 30, 2021 | 115.86 Mn |
| Jun 30, 2021 | 107.22 Mn |